Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 66, 10233-10237, November 1, 2006. doi: 10.1158/0008-5472.CAN-06-1464
© 2006 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Götte, M.
Right arrow Articles by Yip, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Götte, M.
Right arrow Articles by Yip, G. W.
Related Collections
Right arrow Clinical Research
Right arrow Clinical Research: Response Markers and Mechanisms

Reviews

Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective

Martin Götte1 and George W. Yip2

1 Department of Obstetrics and Gynecology, Münster University Hospital, Münster, Germany and 2 Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Requests for reprints: George W. Yip, Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, 4 Medical Drive, Block MD 10, Singapore 117597, Singapore. Phone: 65-6516-3206; Fax: 65-6778-7643; E-mail: georgeyip{at}nus.edu.sg.

Glycosaminoglycans are major constituents of the cancer cell surface and the tumor stroma. The heparan sulfate degrading enzyme heparanase, hyaluronan, and its receptor CD44 are up-regulated in breast cancer, generating a microenvironment that promotes tumor progression and metastasis. Recent experimental and clinical evidence shows that heparanase, hyaluronan, and CD44 regulate cancer cell proliferation, migration, and invasion, as well as tumor-associated angiogenesis and are correlated with patient survival. These findings suggest that they may be used as prognostic factors and targets for breast cancer treatment. (Cancer Res 2006; 66(21): 10233-7)




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. Ganesh, M. Gonzalez-Edick, D. Gibbons, M. Van Roey, and K. Jooss
Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models
Clin. Cancer Res., June 15, 2008; 14(12): 3933 - 3941.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. B. Wallach-Dayan, A. M. Rubinstein, C. Hand, R. Breuer, and D. Naor
DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis
Mol. Cancer Ther., June 1, 2008; 7(6): 1615 - 1623.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
X. Li, S. L Nott, Y. Huang, R. Hilf, R. A Bambara, X. Qiu, A. Yakovlev, S. Welle, and M. Muyan
Gene expression profiling reveals that the regulation of estrogen-responsive element-independent genes by 17{beta}-estradiol-estrogen receptor {beta} is uncoupled from the induction of phenotypic changes in cell models
J. Mol. Endocrinol., May 1, 2008; 40(5): 211 - 229.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. A. Maxwell, J. McCarthy, and E. Turley
Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
J. Cell Sci., April 1, 2008; 121(7): 925 - 932.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Golshani, L. Lopez, V. Estrella, M. Kramer, N. Iida, and V. B. Lokeshwar
Hyaluronic Acid Synthase-1 Expression Regulates Bladder Cancer Growth, Invasion, and Angiogenesis through CD44
Cancer Res., January 15, 2008; 68(2): 483 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
P. Karihtala, Y. Soini, P. Auvinen, R. Tammi, M. Tammi, and V.-M. Kosma
Hyaluronan in Breast Cancer: Correlations With Nitric Oxide Synthases and Tyrosine Nitrosylation
J. Histochem. Cytochem., December 1, 2007; 55(12): 1191 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Ouhtit, Z. Y. Abd Elmageed, M. E. Abdraboh, T. F. Lioe, and M. H.G. Raj
In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the Liver
Am. J. Pathol., December 1, 2007; 171(6): 2033 - 2039.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
I. Cohen, B. Maly, I. Simon, A. Meirovitz, E. Pikarsky, E. Zcharia, T. Peretz, I. Vlodavsky, and M. Elkin
Tamoxifen Induces Heparanase Expression in Estrogen Receptor Positive Breast Cancer
Clin. Cancer Res., July 15, 2007; 13(14): 4069 - 4077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Hamilton, S. F. Fard, F. F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J. B. McCarthy, M. J. Bissell, J. Koropatnick, and E. A. Turley
The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells
J. Biol. Chem., June 1, 2007; 282(22): 16667 - 16680.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.